• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH TX2 TAA ENDOVASCULAR GRAFT PROXIMAL TAPERED COMPONENT; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH TX2 TAA ENDOVASCULAR GRAFT PROXIMAL TAPERED COMPONENT; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number G53449
Medical Device Problem Codes Device Dislodged or Dislocated (2923); No Apparent Adverse Event (3189)
Health Effect - Clinical Codes Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581); No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Catalog# is unknown but referred to as unknown zteg.(b)(4).Investigation is still in progress.
 
Event or Problem Description
Description of event according to initial reporter: component separation between zteg 2pt 38 to 34 (the second spreadsheet says ¿zteg 2pt 38-202¿ and main body (34 proximal).A.(¿component separation¿ listed as device related in the final fda report).Patient outcome: according to the initial reporter, the patient did not experience any adverse effects due to this occurrence.The patient did not require any additional procedures due to this occurrence.
 
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Blank fields on this form indicate the information is unknown or unavailable.Investigation is still in progress.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
Additional information received (b)(6) 2022: rpn og lot#.
 
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Summary of investigational findings: a 71-year-old female with a very tortuous taaa with sma occlusion underwent left ilio-sma bypass on (b)(6) 2012, taa placement to exclude the proximal portion of the aneurysm on (b)(6) 2012, followed by a custom 3-vessel branched stent-graft placement to exclude the reminder of the aneurysm on (b)(6) 2013.All vessels were patent and there was no endoleak at the conclusion of the case.Follow-up visits had been unremarkable until (b)(6) 2014, the ct scan revealed a component separation between the branched device and the bifurcated device.This was successfully repaired on (b)(6) 2014.Patient was withdrawn from the study on (b)(6) 2017.Review of device history record gave no indication of the device being produced outside of specifications.Ct and angio is provided, and an imaging review are performed.Per the findings of the imaging reviewer ¿the zteg-2pt-38-202-pf-us successfully excluded the tortuous thoracic aortic aneurysm on all the follow up imaging¿ and ¿the fen pararenal branched graft was initially inserted two stents into the zteg-2pt-38-202-pf-us.The overlap decreased to one stent when the bifurcated graft and fen pararenal branched graft separation was discovered 22aug2014.There was no endoleak or thoracic aneurysm growth¿.Based on these findings the imaging reviewer impression is ¿the complaint of zteg-2pt-38-202-pf-us and fen pararenal branched graft separation is not confirmed¿.Based on the findings in the imaging review no separation or endoleak in relation to the complaint device were found.After investigation the event for this pr350400 is no longer reportable cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH TX2 TAA ENDOVASCULAR GRAFT PROXIMAL TAPERED COMPONENT
Common Device Name
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
Manufacturer (Section G)
WILLIAM COOK EUROPE
sandet 6, dk-4632
bjaeverskov
Manufacturer Contact
lissi walmann
sandet 6, dk-4632
bjaeverskov 
MDR Report Key13256972
Report Number3002808486-2022-00021
Device Sequence Number4726898
Product Code MIH
UDI-Device Identifier10827002534497
UDI-Public(01)10827002534497(17)141201(10)E2840931
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2012
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberG53449
Device Catalogue NumberZTEG-2PT-38-202-PF-US
Device Lot NumberE2840931
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/20/2021
Supplement Date Received by Manufacturer01/19/2022
06/30/2022
Initial Report FDA Received Date01/14/2022
Supplement Report FDA Received Date01/27/2022
07/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient SexUnknown
-
-